Startups touting at-home coronavirus tests suspend plans after FDA warning

A handful of startups working on at-home #coronavirus test kits have suspended their efforts after new guidance from the FDA.
Several companies working on at-home coronavirus tests have suspended their efforts after new input from the FDA. Source: Bruce Bennett/Getty Images

In a rapid about-face, a handful of startups that had already rolled out at-home coronavirus test kits or planned to start selling them soon have suspended their efforts. It’s the latest twist in an ongoing situation that has unfolded as tech companies have rushed to fill testing gaps with direct-to-consumer kits — and as regulators have rushed to wrangle them.

Late last week, several startups told that the new tests may not meet the Food and Drug Administration’s high standards for traditional approval, however, and cautioned that consumers might not get an accurate result if they didn’t swab deep enough in their nose or throat.

Citiți o mostră, înregistrați-vă pentru a citi în continuare.

Mai multe de la STAT

STAT1 min cititeBiology
STAT+: Pharmalittle: Pfizer-BioNTech Vaccine Seems To Work Against Covid-19 Mutation; Sarepta Gene Therapy Shows Mixed Results
United Kingdom regulators cleared the Moderna Covid-19 vaccine, adding a third shot for emergency use against the pandemic as infections surge there.
STAT1 min cititeAmerican Government
STAT+: Pharmalittle: Biden Taps Kessler To Lead Operation Warp Speed; Trump Administration Seeks Term Limits On Top FDA, CDC Scientists
President-elect Joe Biden has chosen David Kessler to help lead Operation Warp Speed, the program to accelerate development of Covid-19 vaccines and treatments.
STAT1 min cititeMedical
STAT+: Pharmalittle: Pfizer And BioNTech Say Vaccine Is Effective Against Covid-19 Variant; U.S. To Join COVAX Initiative
The Pfizer-BioNTech Covid-19 vaccine appears to work just as well against a fast-spreading variant first identified in the U.K. as it does against earlier forms of the coronavirus.